Takahiro Shibata
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Takahiro Shibata has a total of 392 co-authors. Here are the top co-authors by number of shared publications:
- Koji Uchida
Graduate School of Agricultural and Life Sciences, The University of Tokyo, Tokyo, Japan
69 shared publications Fumie Nakashima
Nagoya University
17 shared publicationsKoji Uchida
The University of Tokyo
15 shared publicationsJun Yoshitake
Institute of Nano‐Life‐Systems, Institutes of Innovation for Future Society Nagoya University Nagoya Japan
8 shared publicationsMiho Chikazawa
Graduate School of Agricultural and Life Sciences, University of Tokyo, Tokyo 113-8657, Japan, and
8 shared publicationsMitsugu Akagawa
Department of Food and Nutrition, Institute of Biomedical Sciences, Tokushima University Graduate School, 2−24, Shinkura-cho, Tokushima 770−0855, Japan
8 shared publications
Latest Publications
- 13 August 2026
- Published by American Chemical Society (ACS) in Biochemistry
- Vol. 65 (17) , 2689-2698
Adductome-Based Identification of Novel Oxidized Phospholipid-Lysine Adducts Formed in Low-Density Lipoprotein
The oxidative modification of low-density lipoprotein (LDL) is involved in the generation of lipid peroxidation-derived electrophilic aldehydes, which covalently react with apolipoprotein B-100 to form various adducts. Although the oxidative modification of LDL is critical in the pathogenesis of atherosclerosis, the structural properties of adducts in oxidized LDL (oxLDL) remain unclear. Thus, we aimed to characterize oxLDL using the adductome approach, a comprehensive mass spectrometry-based analysis designed to detect specific product ions from positively ionized oxidized phosphatidylcholine (oxPC) adducts. The amounts of several adducts, including four major oxPC-lysine (oxPC-Lys) adducts, prominently increased when LDL was oxidized with Cu2+. Analysis of the synthetic adduct candidates through mass spectrometry revealed two oxPC-Lys Schiff base adducts and two novel oxPC-Lys amide-type adducts as the major lysine adducts in oxLDL. The oxPC-Lys Schiff base adducts could be transformed into stable amide-type adducts during LDL oxidation. The amounts of oxPC-Lys adducts were significantly higher in the sera of hyperlipidemic mice than in the sera of control mice. The recognition of oxPC-Lys adducts by macrophages suggested that these adducts were involved in the phagocytosis of oxLDL by macrophages. These findings provide insights into the structural properties of lipoproteins modified under oxidative stress and their biological implications. Moreover, this study is the first to identify and quantify oxPC-Lys amide-type adducts in vitro and in vivo.
- 13 August 2026
- Published by American Chemical Society (ACS) in Biochemistry
- Vol. 65 (17) , 2689-2698
Adductome-Based Identification of Novel Oxidized Phospholipid-Lysine Adducts Formed in Low-Density Lipoprotein
The oxidative modification of low-density lipoprotein (LDL) is involved in the generation of lipid peroxidation-derived electrophilic aldehydes, which covalently react with apolipoprotein B-100 to form various adducts. Although the oxidative modification of LDL is critical in the pathogenesis of atherosclerosis, the structural properties of adducts in oxidized LDL (oxLDL) remain unclear. Thus, we aimed to characterize oxLDL using the adductome approach, a comprehensive mass spectrometry-based analysis designed to detect specific product ions from positively ionized oxidized phosphatidylcholine (oxPC) adducts. The amounts of several adducts, including four major oxPC-lysine (oxPC-Lys) adducts, prominently increased when LDL was oxidized with Cu2+. Analysis of the synthetic adduct candidates through mass spectrometry revealed two oxPC-Lys Schiff base adducts and two novel oxPC-Lys amide-type adducts as the major lysine adducts in oxLDL. The oxPC-Lys Schiff base adducts could be transformed into stable amide-type adducts during LDL oxidation. The amounts of oxPC-Lys adducts were significantly higher in the sera of hyperlipidemic mice than in the sera of control mice. The recognition of oxPC-Lys adducts by macrophages suggested that these adducts were involved in the phagocytosis of oxLDL by macrophages. These findings provide insights into the structural properties of lipoproteins modified under oxidative stress and their biological implications. Moreover, this study is the first to identify and quantify oxPC-Lys amide-type adducts in vitro and in vivo.
- 8 August 2026
- Published by American Chemical Society (ACS) in The Journal of Organic Chemistry
- Vol. 91 (33) , 11587-11590
Total Synthesis of Hemiketal D2 via a Convergent Coupling Strategy
Hemiketal D2 (HKD2) is a recently identified eicosanoid produced from arachidonic acid via a crossover pathway involving 5-lipoxygenase (5-LOX) and cyclooxygenase-2 (COX-2), and has been shown to stimulate angiogenesis by inducing endothelial cell tubulogenesis. However, its limited availability by enzymatic reactions has hindered detailed biological investigation. Herein, we report the first total synthesis of HKD2 through a convergent coupling of three segments bearing all required stereogenic centers. Key transformations include addition of dithiane anion to a lactone segment to construct the hemiacetal moiety and a late-stage cross metathesis with carboxylic acid segment to complete the synthesis.
- 8 August 2026
- Published by American Chemical Society (ACS) in The Journal of Organic Chemistry
- Vol. 91 (33) , 11587-11590
Total Synthesis of Hemiketal D2 via a Convergent Coupling Strategy
Hemiketal D2 (HKD2) is a recently identified eicosanoid produced from arachidonic acid via a crossover pathway involving 5-lipoxygenase (5-LOX) and cyclooxygenase-2 (COX-2), and has been shown to stimulate angiogenesis by inducing endothelial cell tubulogenesis. However, its limited availability by enzymatic reactions has hindered detailed biological investigation. Herein, we report the first total synthesis of HKD2 through a convergent coupling of three segments bearing all required stereogenic centers. Key transformations include addition of dithiane anion to a lactone segment to construct the hemiacetal moiety and a late-stage cross metathesis with carboxylic acid segment to complete the synthesis.
- 25 July 2026
- Published by Wiley in Chemistry – An Asian Journal
- Vol. 21 (14) , e70906
Backbone N ‐Methylation Improves PPCA‐Binding of a Stylissatin A Analogue via Conformational Modulation
Obesity is associated with dysregulated intracellular signaling that controls metabolic homeostasis and inflammatory responses. The marine‐derived cyclic heptapeptide stylissatin A (SA) and its analog d ‐Tyr 1 ( t Bu)‐SA ( 1 ) localize to lysosomes and inhibit the interaction between the protective protein cathepsin A (PPCA) and neuraminidase 1 (Neu1), thereby promoting lipid droplet degradation and suppressing fat accumulation. To improve cellular uptake and therapeutic efficacy, we introduced N ‐methylation into the macrocyclic backbone of 1 and synthesized a new analog, d ‐Tyr 1 ( t Bu)‐ N‐ Me‐Ile 4 ‐SA ( 2 ), via solid‐phase peptide synthesis followed by solution‐phase macrocyclization. N ‐methylation at Ile 4 induced a marked conformational change from cis ‐Pro 3 to trans ‐Pro 3 and increased conformational flexibility in solution. Upon binding to PPCA, this flexibility triggered a transition at Pro 5 from trans to cis . The enhanced hydrophobicity further promoted favorable interactions within the binding pocket. Consequently, 2 exhibited improved anti‐inflammatory and similar anti‐adipogenic activities compared to 1 . Furthermore, the biotin analog of 2 exhibited a higher binding affinity to activated PPCA with a K D value 29‐fold smaller than that of 1 , demonstrating the functional advantage of backbone N ‐methylation. This PPCA–Neu1 interaction‐inhibitory mechanism differs from that of glucagon‐like peptide‐1 (GLP‐1) receptor agonists, highlighting a distinct intracellular therapeutic strategy for the development of next‐generation anti‐obesity agents.
- 25 July 2026
- Published by Wiley in Chemistry – An Asian Journal
- Vol. 21 (14) , e70906
Backbone N ‐Methylation Improves PPCA‐Binding of a Stylissatin A Analogue via Conformational Modulation
Obesity is associated with dysregulated intracellular signaling that controls metabolic homeostasis and inflammatory responses. The marine‐derived cyclic heptapeptide stylissatin A (SA) and its analog d ‐Tyr 1 ( t Bu)‐SA ( 1 ) localize to lysosomes and inhibit the interaction between the protective protein cathepsin A (PPCA) and neuraminidase 1 (Neu1), thereby promoting lipid droplet degradation and suppressing fat accumulation. To improve cellular uptake and therapeutic efficacy, we introduced N ‐methylation into the macrocyclic backbone of 1 and synthesized a new analog, d ‐Tyr 1 ( t Bu)‐ N‐ Me‐Ile 4 ‐SA ( 2 ), via solid‐phase peptide synthesis followed by solution‐phase macrocyclization. N ‐methylation at Ile 4 induced a marked conformational change from cis ‐Pro 3 to trans ‐Pro 3 and increased conformational flexibility in solution. Upon binding to PPCA, this flexibility triggered a transition at Pro 5 from trans to cis . The enhanced hydrophobicity further promoted favorable interactions within the binding pocket. Consequently, 2 exhibited improved anti‐inflammatory and similar anti‐adipogenic activities compared to 1 . Furthermore, the biotin analog of 2 exhibited a higher binding affinity to activated PPCA with a K D value 29‐fold smaller than that of 1 , demonstrating the functional advantage of backbone N ‐methylation. This PPCA–Neu1 interaction‐inhibitory mechanism differs from that of glucagon‐like peptide‐1 (GLP‐1) receptor agonists, highlighting a distinct intracellular therapeutic strategy for the development of next‐generation anti‐obesity agents.
- Open Access
- 4 February 2026
- Published by Elsevier in Journal of Biological Chemistry
- Vol. 302 (3) , 111232
A missense mutation in acyl-CoA synthetase ACSL4 reveals essential residues for catalytic activity in ferroptosis
- 4 February 2026
- Published by Elsevier in Journal of Biological Chemistry
- Vol. 302 (3) , 111232
Open AccessA missense mutation in acyl-CoA synthetase ACSL4 reveals essential residues for catalytic activity in ferroptosis
- 21 November 2025
- Published by American Chemical Society (ACS) in Biochemistry
- Vol. 64 (24) , 4758-4767
Structural and Functional Basis of G Protein-Coupled Receptor 35 Activation by Pyrroloquinoline Quinone
Pyrroloquinoline quinone (PQQ), an o-quinone-type nutrient, has been shown to exert diverse beneficial effects on the biochemical and physiological processes of mammals. However, the molecular mechanisms underlying these effects remain incompletely understood. Here, through screening of metabolite-sensing G protein-coupled receptors (GPCRs)─which respond to metabolites produced by gut microbiota or derived from nutrients─we found that PQQ selectively activates G-protein-coupled receptor 35 (GPR35) and characterized the molecular basis of its ligand recognition. Using a transforming growth factor α shedding assay, we demonstrated that PQQ selectively activated GPR35, a class A rhodopsin-like GPCR expressed in various tissues, including adipose tissue and the gastrointestinal tract. PQQ also promoted β-arrestin 1 recruitment to the plasma membrane, further supporting its role as a GPR35 agonist. Direct binding of PQQ to GPR35 was demonstrated using a clickable photoaffinity probe derived from PQQ. Molecular docking simulation and site-directed mutagenesis revealed that the 2-carboxylic acid moiety of PQQ forms critical hydrogen bonds with Arg100, Tyr101, and Arg151 of GPR35. Additionally, Phe163 appears to contribute to π-H interaction with PQQ. These findings indicate that PQQ functions as a food-derived agonist of GPR35 and provide new insights into the molecular mechanisms underlying the potential beneficial effects of PQQ.
- 21 November 2025
- Published by American Chemical Society (ACS) in Biochemistry
- Vol. 64 (24) , 4758-4767
Structural and Functional Basis of G Protein-Coupled Receptor 35 Activation by Pyrroloquinoline Quinone
Pyrroloquinoline quinone (PQQ), an o-quinone-type nutrient, has been shown to exert diverse beneficial effects on the biochemical and physiological processes of mammals. However, the molecular mechanisms underlying these effects remain incompletely understood. Here, through screening of metabolite-sensing G protein-coupled receptors (GPCRs)─which respond to metabolites produced by gut microbiota or derived from nutrients─we found that PQQ selectively activates G-protein-coupled receptor 35 (GPR35) and characterized the molecular basis of its ligand recognition. Using a transforming growth factor α shedding assay, we demonstrated that PQQ selectively activated GPR35, a class A rhodopsin-like GPCR expressed in various tissues, including adipose tissue and the gastrointestinal tract. PQQ also promoted β-arrestin 1 recruitment to the plasma membrane, further supporting its role as a GPR35 agonist. Direct binding of PQQ to GPR35 was demonstrated using a clickable photoaffinity probe derived from PQQ. Molecular docking simulation and site-directed mutagenesis revealed that the 2-carboxylic acid moiety of PQQ forms critical hydrogen bonds with Arg100, Tyr101, and Arg151 of GPR35. Additionally, Phe163 appears to contribute to π-H interaction with PQQ. These findings indicate that PQQ functions as a food-derived agonist of GPR35 and provide new insights into the molecular mechanisms underlying the potential beneficial effects of PQQ.
- Open Access
- 29 October 2025
- Published by Wiley in The FEBS Journal
- Vol. 293 (5) , 1386-1399
Dietary anthocyanidin pelargonidin activates G protein‐coupled receptor 35
G protein‐coupled receptors (GPCRs) are the largest superfamily of cell surface receptors. They regulate critical physiological events and serve as potential therapeutic targets. G protein‐coupled receptor 35 (GPR35), a class A rhodopsin‐like GPCR expressed in various tissues, including adipose tissue and the gastrointestinal tract, has roles in diverse functions, including antioxidant, anticarcinogenic, and anti‐inflammatory effects. Although many endogenous and synthetic GPR35 agonists have been identified, the understanding of food‐derived agonists is limited. In this study, we discovered pelargonidin as a newly identified food‐derived GPR35 agonist through a systematic screening approach. We evaluated 28 dietary phytochemicals using a transforming growth factor α (TGFα) shedding assay to evaluate GPR35 activation, and found that cyanidin, a common 3‐hydroxyanthocyanidin present in various red fruits and vegetables, induced GPR35 activation. Among a series of 3‐hydroxyanthocyanidins tested, pelargonidin, characterized by its monohydroxylated B‐ring, exhibited the most potent agonistic activity. Mutational studies demonstrated that the hydrogen bond between the 3‐hydroxy group in the C‐ring of pelargonidin and Asn169, as well as the hydrophobic interaction between the A‐ring of pelargonidin and Phe163, is crucial for GPR35 activation. Furthermore, pelargonidin inhibited the production of interleukin‐8, a pro‐inflammatory cytokine, by activating endogenous GPR35 in Caco‐2 cells. These findings suggest that GPR35 may serve as a potential receptor for dietary anthocyanidins, such as pelargonidin, and provide new insights into the molecular mechanisms underlying the potential chemopreventive effects of anthocyanidins.
- 29 October 2025
- Published by Wiley in The FEBS Journal
- Vol. 293 (5) , 1386-1399
Open AccessDietary anthocyanidin pelargonidin activates G protein‐coupled receptor 35
G protein‐coupled receptors (GPCRs) are the largest superfamily of cell surface receptors. They regulate critical physiological events and serve as potential therapeutic targets. G protein‐coupled receptor 35 (GPR35), a class A rhodopsin‐like GPCR expressed in various tissues, including adipose tissue and the gastrointestinal tract, has roles in diverse functions, including antioxidant, anticarcinogenic, and anti‐inflammatory effects. Although many endogenous and synthetic GPR35 agonists have been identified, the understanding of food‐derived agonists is limited. In this study, we discovered pelargonidin as a newly identified food‐derived GPR35 agonist through a systematic screening approach. We evaluated 28 dietary phytochemicals using a transforming growth factor α (TGFα) shedding assay to evaluate GPR35 activation, and found that cyanidin, a common 3‐hydroxyanthocyanidin present in various red fruits and vegetables, induced GPR35 activation. Among a series of 3‐hydroxyanthocyanidins tested, pelargonidin, characterized by its monohydroxylated B‐ring, exhibited the most potent agonistic activity. Mutational studies demonstrated that the hydrogen bond between the 3‐hydroxy group in the C‐ring of pelargonidin and Asn169, as well as the hydrophobic interaction between the A‐ring of pelargonidin and Phe163, is crucial for GPR35 activation. Furthermore, pelargonidin inhibited the production of interleukin‐8, a pro‐inflammatory cytokine, by activating endogenous GPR35 in Caco‐2 cells. These findings suggest that GPR35 may serve as a potential receptor for dietary anthocyanidins, such as pelargonidin, and provide new insights into the molecular mechanisms underlying the potential chemopreventive effects of anthocyanidins.
- Open Access
- 4 September 2025
- Published by Elsevier in Journal of Biological Chemistry
- Vol. 301 (10) , 110684
Adductome-based identification of lysine monomethylation as a key post-translational protein modification in autoimmune diseases
- 4 September 2025
- Published by Elsevier in Journal of Biological Chemistry
- Vol. 301 (10) , 110684
Open AccessAdductome-based identification of lysine monomethylation as a key post-translational protein modification in autoimmune diseases
- Open Access
Effect of 1-Kestose on Lipid Metabolism in a High-Fat-Diet Rat Model
Objectives: Hyperlipidemia is a risk factor for various diseases. Identifying food components that can help reduce the levels of blood lipids, such as cholesterol and triglycerides, is a global research priority. It has been reported that 1-Kestose, a fructooligosaccharide, can reduce blood cholesterol and triglyceride levels in rats; however, the underlying mechanisms remain unclear. Therefore, we aimed to elucidate the effects of 1-kestose supplementation on lipid metabolism and the gut environment in rats. Methods: Twenty male Sprague–Dawley rats (age 8 weeks) were provided 1-kestose-containing water and were maintained for two weeks. After dissection, the blood components, hepatic gene expression, gut microbiota, and bile acid composition in the cecal contents of the rats were analyzed. Results: The 1-Kestose intake reduced plasma cholesterol and triglyceride levels. Additionally, an increase in cytochrome P450 family 7 subfamily A member 1 mRNA expression, a key gene for bile acid synthesis in the liver, and a decrease in lipid synthesis-related mRNA expression were observed. In the cecum, the levels of deconjugated bile acids, which are involved in the regulation of lipid synthesis, were increased. Furthermore, the 1-kestose intake altered the gut microbiota in the cecum, leading to an increase in the abundance of specific bacteria, such as Bifidobacterium, which are involved in the deconjugation of conjugated bile acids. Conclusions: The intake of 1-kestose alters the gut microbiota and bile acid metabolism in the cecum, potentially influencing lipid metabolism in the host.
Open AccessEffect of 1-Kestose on Lipid Metabolism in a High-Fat-Diet Rat Model
Objectives: Hyperlipidemia is a risk factor for various diseases. Identifying food components that can help reduce the levels of blood lipids, such as cholesterol and triglycerides, is a global research priority. It has been reported that 1-Kestose, a fructooligosaccharide, can reduce blood cholesterol and triglyceride levels in rats; however, the underlying mechanisms remain unclear. Therefore, we aimed to elucidate the effects of 1-kestose supplementation on lipid metabolism and the gut environment in rats. Methods: Twenty male Sprague–Dawley rats (age 8 weeks) were provided 1-kestose-containing water and were maintained for two weeks. After dissection, the blood components, hepatic gene expression, gut microbiota, and bile acid composition in the cecal contents of the rats were analyzed. Results: The 1-Kestose intake reduced plasma cholesterol and triglyceride levels. Additionally, an increase in cytochrome P450 family 7 subfamily A member 1 mRNA expression, a key gene for bile acid synthesis in the liver, and a decrease in lipid synthesis-related mRNA expression were observed. In the cecum, the levels of deconjugated bile acids, which are involved in the regulation of lipid synthesis, were increased. Furthermore, the 1-kestose intake altered the gut microbiota in the cecum, leading to an increase in the abundance of specific bacteria, such as Bifidobacterium, which are involved in the deconjugation of conjugated bile acids. Conclusions: The intake of 1-kestose alters the gut microbiota and bile acid metabolism in the cecum, potentially influencing lipid metabolism in the host.
- 25 May 2024
- Published by Oxford University Press (OUP) in Bioscience, Biotechnology, and Biochemistry
- Vol. 88 (8) , 948-955
Seabuckthorn (Hippophae rhamnoides, L.) pulp oil prevents ultraviolet-induced damage in human fibroblasts
Seabuckthorn pulp oil (SBO) is used in beauty products because of its rich lipophilic substances with high nutraceutical and cosmeceutical potential. However, the mechanism through which SBO enhances skin elasticity remains unclear. Therefore, in this study, we examined the anti-photoaging activity of SBO in normal human dermal fibroblasts (NHDF) under ultraviolet (UV) irradiation. Pretreatment with SBO significantly suppressed UV-B-induced cell toxicity and collagen degradation, suggesting that SBO contains anti-photoaging substances. Further, palmitoleic acid, the main component of SBO, maintained cell viability and collagen levels in UV-B-irradiated NHDF by suppressing the expression of matrix metalloproteinase 1 and acted on the inhibition of p38 and JNK phosphorylation and nuclear translocation of nuclear factor-kappa B. These findings suggest the utility of SBO as an anti-photoaging agent.
- 25 May 2024
- Published by Oxford University Press (OUP) in Bioscience, Biotechnology, and Biochemistry
- Vol. 88 (8) , 948-955
Seabuckthorn (Hippophae rhamnoides, L.) pulp oil prevents ultraviolet-induced damage in human fibroblasts
Seabuckthorn pulp oil (SBO) is used in beauty products because of its rich lipophilic substances with high nutraceutical and cosmeceutical potential. However, the mechanism through which SBO enhances skin elasticity remains unclear. Therefore, in this study, we examined the anti-photoaging activity of SBO in normal human dermal fibroblasts (NHDF) under ultraviolet (UV) irradiation. Pretreatment with SBO significantly suppressed UV-B-induced cell toxicity and collagen degradation, suggesting that SBO contains anti-photoaging substances. Further, palmitoleic acid, the main component of SBO, maintained cell viability and collagen levels in UV-B-irradiated NHDF by suppressing the expression of matrix metalloproteinase 1 and acted on the inhibition of p38 and JNK phosphorylation and nuclear translocation of nuclear factor-kappa B. These findings suggest the utility of SBO as an anti-photoaging agent.
- Open Access
- 23 May 2024
- Published by Wiley in The FASEB Journal
- Vol. 38 (10) , e23688
Isocitrate dehydrogenase 1 upregulation in urinary extracellular vesicles from proximal tubules of type 2 diabetic rats
Diabetic nephropathy (DN) is a major cause of chronic kidney disease. Microalbuminuria is currently the most common non‐invasive biomarker for the early diagnosis of DN. However, renal structural damage may have advanced when albuminuria is detected. In this study, we sought biomarkers for early DN diagnosis through proteomic analysis of urinary extracellular vesicles (uEVs) from type 2 diabetic model rats and normal controls. Isocitrate dehydrogenase 1 (IDH1) was significantly increased in uEVs from diabetic model rats at the early stage despite minimal differences in albuminuria between the groups. Calorie restriction significantly suppressed the increase in IDH1 in uEVs and 24‐hour urinary albumin excretion, suggesting that the increase in IDH1 in uEVs was associated with the progression of DN. Additionally, we investigated the origin of IDH1‐containing uEVs based on their surface sugar chains. Lectin affinity enrichment and immunohistochemical staining showed that IDH1‐containing uEVs were derived from proximal tubules. These findings suggest that the increase in IDH1 in uEVs reflects pathophysiological alterations in the proximal tubules and that IDH1 in uEVs may serve as a potential biomarker of DN in the proximal tubules.
- 23 May 2024
- Published by Wiley in The FASEB Journal
- Vol. 38 (10) , e23688
Open AccessIsocitrate dehydrogenase 1 upregulation in urinary extracellular vesicles from proximal tubules of type 2 diabetic rats
Diabetic nephropathy (DN) is a major cause of chronic kidney disease. Microalbuminuria is currently the most common non‐invasive biomarker for the early diagnosis of DN. However, renal structural damage may have advanced when albuminuria is detected. In this study, we sought biomarkers for early DN diagnosis through proteomic analysis of urinary extracellular vesicles (uEVs) from type 2 diabetic model rats and normal controls. Isocitrate dehydrogenase 1 (IDH1) was significantly increased in uEVs from diabetic model rats at the early stage despite minimal differences in albuminuria between the groups. Calorie restriction significantly suppressed the increase in IDH1 in uEVs and 24‐hour urinary albumin excretion, suggesting that the increase in IDH1 in uEVs was associated with the progression of DN. Additionally, we investigated the origin of IDH1‐containing uEVs based on their surface sugar chains. Lectin affinity enrichment and immunohistochemical staining showed that IDH1‐containing uEVs were derived from proximal tubules. These findings suggest that the increase in IDH1 in uEVs reflects pathophysiological alterations in the proximal tubules and that IDH1 in uEVs may serve as a potential biomarker of DN in the proximal tubules.